BioTech

Abbott (NYSE: ABT) today announced the U.S. Food and Drug Administration (FDA) approved the Amplatzer Piccolo™ Occluder, the world's first medical device that can be implanted in the tiniest...

Source: www.novartis.com The US Food and Drug Administration (FDA) has granted Novartis Breakthrough Therapy designation for its investigational therapy crizanlizumab (SEG101). This revolutionary treatment is...

Lilly makes $8 billion bet on drugs for rare cancers with Loxo Oncology buy

Source: www.news.sanofi.us The U.S. Food and Drug Administrator (FDA) has given its approval for Sanofi and Merck’s drug VAXELIS. This drug can be used as...

MARLBOROUGH, Mass., Dec. 27, 2018 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it exercised its option to acquire th

My WordPress Blog

Novartis have appointed Susanne Schaffert, Ph.D., as the new CEO of Novartis Oncology  Novartis announced that Susanne Schaffert, Ph.D., currently President, Advanced Accelerator Applications (AAA), a Novartis company, has been appointed CEO Novartis Oncology. She will report to Vas Narasimhan, CEO, Novartis, and will join the Executive Committee on January 1, 2019. Liz Barrett will be...

Pfizer Inc. (NYSE: PFE) and GlaxoSmithKline plc (NYSE:GSK) today announced they have entered into an agreement to create a premier global consumer hea

SUZHOU, China, Dec. 16, 2018 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801) and Incyte (NASDAQ:INCY) today announced that th

Source: www.novartis.com Novartis announced the approval of Xolair (omalizumab) by the European Commission. Xolair is a prefilled syringe that patients with severe allergic asthma and chronic...